VulnerabilityModified
CVE-2017-17677
BMC Remedy 9.1SP3 is affected by authenticated code execution.
HIGH 8.8EPSS 1.06%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (1.06%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.
- CVSS 3.1
- 8.8 HIGHCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 1.06% probability · 63th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-732
- Affected
- bmc/remedy mid-tier
- Source
- cve@mitre.org
References
- https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.htmlRelease Notes, Vendor Advisory
- https://seclists.org/fulldisclosure/2017/Oct/52Mailing List, Third Party Advisory
- https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.htmlRelease Notes, Vendor Advisory
- https://seclists.org/fulldisclosure/2017/Oct/52Mailing List, Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.